Trademark: 79207107
Word
DEMENTIA DISCOVERY FUND
Status Date
Tuesday, June 23, 2020
Filing Date
Thursday, July 14, 2016
Abandoned Date
Tuesday, June 23, 2020
5 Pharmaceutical and medical preparations and substances for the prevention and treatment of dementia; sanitary preparations for medical purposes; pharmaceutical preparations, all for use in the treatment or prevention of brain diseases and degenerative dementia disorders; antiseptic preparations; prescription pharmaceuticals for humans for the prevention and treatment of dementia; veterinary and sanitary products, namely, antibiotics; dietary food supplements; health food supplements; vitamins; dietetic substances adapted for medical use, namely, sugar substitutes; food for babies; foods for medical purposes, namely, food for enteral feeding for teens adults and elders; homeopathic pharmaceuticals for use in the treatment of dementia; medicinal drinks; anti-diabetic drugs; hypertension medications; steroid hormones; non-steroidal anti-inflammatory drugs; chemicals in the nature of medical diagnostic reagents for use in medical and veterinary diagnosis of dementia disorders
36 Insurance, namely, insurance brokerage; financial affairs, namely, financial information, management and analysis services; monetary affairs, namely, monetary exchange and monetary strategic consultation and research; real estate affairs, namely, leasing of real estate, real estate brokerage and real estate appraisal services; financing services in relation to medical research; humanitarian aid and development, namely, charitable fundraising and financial support services for research in dementia; charitable fundraising for dementia research; charitable fundraising for the purchase of food, clothing and medical items for those in need; financial sponsorship of medical research in the field of dementia; financial management and administration of charitable funds for dementia research; distribution and allocation of charitable funds, namely, accepting and administering monetary charitable contributions to fund medical research; credit card and charge card payment processing services; providing of financial information regarding corporate donations and payroll donations by employees; financial information, advisory, and consultancy services in relation to the aforesaid services
44 Medical services; the provision of medical information, online via the Internet, on the subject of all aspects of dementia diseases and the prevention of all types dementia diseases; medical services relating to the science of nutrition and the use of medical and pharmaceutical preparations and substances; medical services in relation to the recommendation and prescribing of medicaments and medical products of all kinds; medical services concerning dementia, namely physician, nursing, midwifery and hospital services; diagnostic and laboratory services, namely, medical testing for diagnostic or treatment purposes; hygienic and beauty care for human beings; agricultural services, namely, agricultural advice; dentistry services; medical analysis for the diagnosis and treatment of individuals and groups of people with dementia including x-ray examinations and taking blood samples; pharmaceutical advice; medical clinic services; medical treatment services; medical analysis services; medical information services; nursing services; information, advisory and consultancy services relating to all the aforesaid, including information provided on-line from a computer database, intranets, extranets and the Internet
42 Scientific and technological services, namely, research and design in the field of pharmaceutical development; scientific and technological services, namely, medical research and product development in the field of dementia; industrial analysis and research services in the field of computer hardware; design and development of computer hardware and software; design and development of computer hardware and software connected with dementia; Laboratory analysis in the field of pharmaceuticals and clinical trials in the pharmaceutical, biotechnology and medical device fields; laboratory research in the field of pharmaceuticals and clinical trials in the pharmaceutical, biotechnology and medical device fields; laboratory testing services in the field of pharmaceutical product testing; medical research laboratory services; medical research services in relation to the causes, symptoms, diagnosis, treatment and prevention of dementia; scientific genetic research in the field of dementia; provision of scientific research facilities in the nature of laboratories; medical research in relation to medicines and pharmaceuticals; medical research services; design and development of mobile device software applications; design and development of computer programs
Dec 2, 2022
Change Of Owner Received From Ib
Jul 11, 2021
Final Decision Transaction Processed By Ib
Jun 23, 2021
Final Disposition Notice Sent To Ib
Jun 23, 2021
Final Disposition Notice Created, To Be Sent To Ib
Jun 18, 2021
New Representative At Ib Received
Jul 9, 2020
New Representative At Ib Received
Jun 23, 2020
Abandonment Notice Mailed - After Ex Parte Appeal
Jun 23, 2020
Abandonment - After Ex Parte Appeal
Jun 23, 2020
Exparte Appeal Terminated
Apr 1, 2020
Ex Parte Appeal-Refusal Affirmed
Nov 20, 2019
Notification Of Examiners Statement E-Mailed
Nov 20, 2019
Examiners Statement E-Mailed
Nov 20, 2019
Examiners Statement - Completed
Sep 30, 2019
Jurisdiction Restored To Examining Attorney
Jul 26, 2019
Notification Of Action Denying Req For Recon E-Mailed
Jul 26, 2019
Action Denying Req For Recon E-Mailed
Jul 26, 2019
Action Continuing Final - Completed
Jun 25, 2019
Ex Parte Appeal-Instituted
Jun 25, 2019
Jurisdiction Restored To Examining Attorney
Jun 20, 2019
Exparte Appeal Received At Ttab
Jun 19, 2019
Notice Of Revival - E-Mailed
Jun 19, 2019
Petition Granted - Ttab Appeal Filed
Jun 19, 2019
Assigned To Petition Staff
May 23, 2019
Exparte Appeal Received At Ttab
May 21, 2019
Teas Response To Office Action Received
May 21, 2019
Teas Petition To Revive Received
May 21, 2019
Exparte Appeal Received At Ttab
Mar 21, 2019
Abandonment Notice E-Mailed - Failure To Respond
Mar 21, 2019
Abandonment Notice Mailed - Failure To Respond
Mar 21, 2019
Abandonment - Failure To Respond Or Late Response
Nov 2, 2018
Notification Of Possible Opposition - Processed By Ib
Oct 17, 2018
Notification Of Possible Opposition Sent To Ib
Oct 17, 2018
Notification Of Possible Opposition Created, To Be Sent To Ib
Oct 11, 2018
New Representative At Ib Received
Sep 5, 2018
Notification Of Final Refusal Emailed
Sep 5, 2018
Final Refusal E-Mailed
Sep 5, 2018
Final Refusal Written
Aug 3, 2018
Teas/Email Correspondence Entered
Aug 2, 2018
Correspondence Received In Law Office
Aug 2, 2018
Teas Response To Office Action Received
Feb 2, 2018
Notification Of Non-Final Action E-Mailed
Feb 2, 2018
Non-Final Action E-Mailed
Feb 2, 2018
Non-Final Action Written
Dec 12, 2017
Teas/Email Correspondence Entered
Dec 11, 2017
Correspondence Received In Law Office
Dec 11, 2017
Teas Response To Office Action Received
Dec 11, 2017
Teas Change Of Correspondence Received
Jul 1, 2017
Refusal Processed By Ib
Jun 9, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Jun 9, 2017
Refusal Processed By Mpu
May 29, 2017
Non-Final Action (Ib Refusal) Prepared For Review
May 28, 2017
Non-Final Action Written
May 17, 2017
Application Filing Receipt Mailed
May 13, 2017
Assigned To Examiner
May 13, 2017
New Application Office Supplied Data Entered In Tram
May 11, 2017
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
